Obesity Clinical Trial
Official title:
Weight Loss Intervention for Mothers With Young Children
Verified date | June 2023 |
Source | Ohio State University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This lifestyle behavior intervention aims to weight loss in low-income overweight or obese mothers of young children through promotion of stress management, healthy eating, and physical activity. All eligible women will be assigned to the intervention group. The intervention will last 3 weeks and will be delivered via weekly web and individual health coaching sessions.
Status | Active, not recruiting |
Enrollment | 30 |
Est. completion date | June 30, 2024 |
Est. primary completion date | December 30, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 45 Years |
Eligibility | Inclusion Criteria: - Body mass index of 25.0-39.9 kg/m2 (calculated using height and weight) - Current enrollment in government assistant programs (for example, WIC, food stamp (SNAP), or Madicaid) - 6 weeks - 3.5 years postpartum - 18-45 years old - Fluency in speaking, reading, and writing English - Ownership of a smart phone with unlimited text messages and internet access - Committed to a three-week intervention study Exclusion Criteria: - Current pregnancy or lactation - Plan to become pregnant during the trial - Type 1 or 2 diabetes - Untreated thyroid disease - Drug or alcohol abuse or dependence within last six months - Major psychiatric disorder (e.g., schizophrenia, bipolar) - History of bulimia or anorexia - Current taking of appetite suppressant or (antipsychotic) medications known to affect body weight - Current participation in a weight control or drug study - Current or planned participation in a commercial weight loss program - Previous weight loss surgery - Contraindications to physical activity |
Country | Name | City | State |
---|---|---|---|
United States | The Ohio State University | Columbus | Ohio |
Lead Sponsor | Collaborator |
---|---|
Ohio State University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in body weight | Self-reported body weight | baseline (T1) and 3 weeks follow up (T2) | |
Secondary | Waist circumference | Self-reported pants size will be used to measure waist circumference. Participants will report their current pants size. Values are: 00-0 = extra small, 2-4 = small, 6-8 = medium, 10-12 = large,14-16 = extra large, 18-20 = 2XL, 22-24 =3XL. Higher scores indicate higher waist circumference. | baseline (T1) and 3 weeks follow up (T2) | |
Secondary | Change in dietary fat intake | The NCI brief dietary fat intake survey (16 items) will be used to measure dietary fat intake. Participants will be asked to report the frequency of each specific food that they eat over the past 12 months. Values are:1 = never, 2 = less than once per month,3 = 1-3 times per week, 4 = 3-4 times per week,5 = 5-6 times per week, 6 = 1 time per day, 7 = 2 or more times per day. Higher scores indicate more frequent fat intake. | baseline (T1) and 3 weeks follow up (T2) | |
Secondary | Change in fruit and vegetable intake | The NCI brief fruit and vegetable intake survey (9 items) will be used to measure fruit and vegetable intake. Participants will be asked to report frequency of each specific fruit and vegetable that they eat over the past month. Values are:1 = never, 2 = 1-3 times last month,3 = 1-2 times per week, 4 = 3-4 times per week, 5 = 5-6 times per week, 6 = 1 time per day, 7 = 2 times per day, 8 = 3 times per day, 9 = 4 times per day, 10 = 5 or more times per day. Higher scores indicate more frequent fruit and vegetable intake. | baseline (T1) and 3 weeks follow up (T2) | |
Secondary | Change in added sugar intake | The NCI five-factor screener (4 items) will be used to measure added sugar intake. Participants will be asked to report frequency of each specific soda beverages that they drink over the past month. Values are:1 = never, 2 = 1-3 times last month,3 = 1-2 times per week, 4 = 3-4 times per week, 5 = 5-6 times per week, 6 = 1 time per day, 7 = 2 times per day, 8 = 3 times per day, 9 = 4 times per day, 10 = 5 or more times per day. Higher scores indicate more frequent added sugar intake. | baseline (T1) and 3 weeks follow up (T2) | |
Secondary | Change in physical activity | The International Physical Activity Questionnaire Short Form (7 items) will be used to measure physical activity. Participants will be asked to report frequency (days/week) and duration (hours/ day or minutes/day) of vigorous and moderate physical activities that they did in the past 7 days. Higher scores indicate more physical activity. | baseline (T1) and 3 weeks follow up (T2) | |
Secondary | Change in autonomous motivation for stress management | The Treatment Self-Regulation Questionnaire (6 items) will be used to measure autonomous motivation for stress management. Participants will be asked to report why they manage stress.
Values ranged from 1 to 7: 1 = not at all true, 4 = somewhat true, 7 = very true. Higher scores indicate higher autonomous motivation for stress management. |
baseline (T1) and 3 weeks follow up (T2) | |
Secondary | Change in autonomous motivation for healthy eating | The Treatment Self-Regulation Questionnaire (6 items) will be used to measure autonomous motivation for healthy eating. Participants will be asked to report why they eat healthier foods.
Values ranged from 1 to 7: 1 = not at all true, 4 = somewhat true, 7 = very true. Higher scores indicate higher autonomous motivation for healthy eating. |
baseline (T1) and 3 weeks follow up (T2) | |
Secondary | Change in autonomous motivation for physical activity | The Treatment Self-Regulation Questionnaire (6 items) will be used to measure autonomous motivation for physical activity. Participants will be asked to report why they want to be physically active. Values ranged from 1 to 7: 1 = not at all true, 4 = somewhat true, 7 = very true. Higher scores indicate higher autonomous motivation for physical activity. | baseline (T1) and 3 weeks follow up (T2) | |
Secondary | Change in coping self-efficacy | Survey for coping self-efficacy (10 items) will be used to measure coping self-efficacy. Participants will be asked to report their confidence in coping stress. Values are 1 = not at all confident, 2 = not too confident, 3 =somewhat confident, 4= very confident. Higher scores indicate higher coping self-efficacy. | baseline (T1) and 3 weeks follow up (T2) | |
Secondary | Change in healthy eating self-efficacy | Survey for healthy eating self-efficacy (8 items) will be used to measure healthy eating self-efficacy. Participants will be asked to report their confidence in eating healthier. Values are 1 = not at all confident, 2 = not too confident, 3 =somewhat confident, 4= very confident.
Higher scores indicate higher healthy eating self-efficacy. |
baseline (T1) and 3 weeks follow up (T2) | |
Secondary | Change in physical activity self-efficacy | Survey for healthy eating self-efficacy (10 items) will be used to measure physical activity self-efficacy. Participants will be asked to report their confidence in more physically active. Values are 1 = not at all confident, 2 = not too confident, 3 =somewhat confident, 4= very confident. Higher scores indicate higher physical activity self-efficacy. | baseline (T1) and 3 weeks follow up (T2) | |
Secondary | Change in social support for stress management | A survey (6 items) will be used to measure social support for stress management. The survey assess how often participants asking for family members, friends, co-worker or other people for support when they need it. Values are 1 = rarely or never, 2 = sometimes, 3 = often, 4= usually or always. Higher scores indicate more social support for stress management. | baseline (T1) and 3 weeks follow up (T2) | |
Secondary | Change in social support for healthy eating | A survey (5 items) will be used to measure social support for healthy eating. The survey assess how often participants asking for family members, friends, co-worker or other people for support they they need it. Values are 1 = rarely or never, 2 = sometimes, 3 = often, 4= usually or always. Higher scores indicate more social support for healthy eating. | baseline (T1) and 3 weeks follow up (T2) | |
Secondary | Change in social support for physical activity | A survey (4 items) will be used to measure social support for healthy eating. The survey assess how often participants asking for family members, friends, co-worker or other people for support they they need it. Values are 1 = rarely or never, 2 = sometimes, 3 = often, 4= usually or always. Higher scores indicate more social support for physical activity. | baseline (T1) and 3 weeks follow up (T2) | |
Secondary | Change in emotion regulation | Emotion Regulation Questionnaire (10 items) will be used to assess emotion regulation. This questionnaire assess emotion regulatory process using reappraisal, suppression and regulating negative emotion. The questionnaire has 2 sub scales: reappraisal (6 items) and suppression (4 items). Values are 1 = strongly disagree, 2 = mostly disagree, 3 =somewhat disagree, 4= neither agree or disagree, 5 = somewhat agree, 6 = mostly agree, 7 = strongly agree. Higher scores indicate higher reappraisal or suppression. | baseline (T1) and 3 weeks follow up (T2) | |
Secondary | Change in perceived stress | The perceived stress scale (10 items) will be used to measure perceived stress. This survey measures the degree to which situations in one's life are appraised as stressful.
Values are 0 = never, 1 = almost never, 2 = sometimes, 3 = fairly often, 4= very often Higher scores indicate higher levels of perceived stress. |
baseline (T1) and 3 weeks follow up (T2) | |
Secondary | Change in impulsiveness | The Barratt Impulsiveness scale (30 items) will be used to measure impulsiveness. This survey measures the degree to which situations in one's life are appraised as stressful.
Values are 1 = never, 2 = rarely, 3 = almost always, 4= always. Higher scores indicate less impulsiveness. |
baseline (T1) and 3 weeks follow up (T2) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |